Biology Insights

What Is a Short Cervix and How Is It Treated?

A short cervix can raise the risk of preterm birth, but there are effective ways to manage it. Learn how it’s diagnosed and what treatment options are available.

By Kyle Edmonds

A short cervix refers to a cervix that measures 25 millimeters or less during the second trimester of pregnancy, detected by transvaginal ultrasound. This measurement matters because it is one of the strongest predictors of preterm birth, and catching it early opens the door to treatments that can meaningfully extend a pregnancy. The good news is that several interventions, particularly vaginal progesterone and cervical cerclage, have solid evidence behind them and can roughly cut the risk of very early delivery in half for the right candidates.

What “Short” Actually Means

The cervix is the narrow, lower portion of the uterus that connects to the vaginal canal. During pregnancy, it stays long and firm to keep the baby in place, gradually shortening and softening only near the end of the third trimester as labor approaches. A typical mid-trimester cervical length falls in the range of 35 to 40 mm. When the cervix shortens too early, the risk of preterm delivery rises sharply.

The standard cutoff used in clinical practice is 25 mm or less, measured by transvaginal ultrasound somewhere between 18 and 24 weeks of gestation. About 4 percent of women screened in a large multicentre study had a cervical length at or below this threshold. The shorter the measurement, the higher the risk. A cervix under 15 mm, for example, carries considerably more danger than one measuring 24 mm.

Why the Cervix Shortens Early

Sometimes the cause is identifiable, but in many cases a short cervix shows up without a clear explanation. Broadly, the recognized risk factors fall into a few categories:

Multiple pregnancies also increase the risk, partly because the extra weight and uterine distension put more mechanical pressure on the cervix.

How and When Screening Happens

Cervical length is measured using a transvaginal ultrasound probe placed at the entrance to the vagina. This approach is more accurate than an abdominal ultrasound for getting a clear view of the cervix. The measurement is typically done between 18 and 24 weeks, often piggybacked onto the anatomy scan that most pregnant women have around 20 weeks.

Whether every pregnant woman should be screened, or only those with risk factors, remains a point of debate. A 2024 systematic review and meta-analysis found that universal cervical length screening in singleton pregnancies was associated with a significant reduction in spontaneous preterm birth before 37 weeks compared to no screening. However, the population-level effect is modest. One analysis estimated that in countries where the preterm birth rate sits around 7.4 percent, universal screening plus treatment would only bring it down to about 7.0 percent. That is a real but small benefit set against the logistical demands of scanning millions of women.

Cost-effectiveness analyses have also given mixed signals, largely depending on how effective the treatment is assumed to be. One study found universal screening cost-effective at about $43 per quality-adjusted life year gained, avoiding an estimated 10 neonatal deaths or cases of long-term neurological problems per 100,000 women screened. A more recent model found universal screening actually saved money overall. Other analyses were less optimistic, with outcomes swinging heavily on how much progesterone actually reduces preterm birth in the specific population being modeled. In practice, many institutions now offer universal screening during the mid-trimester anatomy scan, while some still limit it to women with prior preterm births.

Vaginal Progesterone

Vaginal progesterone is the most widely studied first-line treatment for a short cervix in singleton pregnancies. It is typically prescribed as a daily suppository or gel, started once the short cervix is identified and continued until around 36 weeks of gestation. Progesterone helps maintain the structural integrity of the cervix during pregnancy, counteracting the inflammatory and softening processes that contribute to premature shortening.

The evidence supporting vaginal progesterone for singleton pregnancies with a short cervix is strong. A landmark trial published in the New England Journal of Medicine found that spontaneous delivery before 34 weeks occurred in about 19 percent of women receiving progesterone versus 34 percent on placebo, a relative risk reduction of roughly 44 percent. Another large multicenter trial showed that vaginal progesterone gel cut the rate of delivery before 33 weeks nearly in half, from about 16 percent to 9 percent. In that study, treating 14 women whose cervix measured between 10 and 20 mm would prevent one case of very preterm birth.

Clinical guidelines now broadly endorse vaginal progesterone for singleton pregnancies with a cervical length of 25 mm or less, whether or not the woman has a history of preterm birth.

Cervical Cerclage

A cervical cerclage is a stitch placed around the cervix to physically hold it closed, typically done between 12 and 24 weeks of gestation. There are three broad scenarios in which cerclage is considered. A history-indicated cerclage is placed early in pregnancy based on a previous pattern of cervical insufficiency or preterm loss. An ultrasound-indicated cerclage is placed after surveillance shows the cervix shortening. A rescue cerclage is placed as an emergency when the cervix is already dilating and membranes may be bulging.

Compared to no cerclage in women with a singleton pregnancy, prior preterm birth, and a short cervix, cerclage reduced preterm birth before 32 weeks by about a third and lowered composite perinatal morbidity and mortality by about 36 percent. The benefit is especially clear for women with a history of spontaneous preterm birth. In that group, one study found cerclage-treated women delivered at a mean of about 35 weeks versus roughly 32 weeks with conservative management, and perinatal death rates dropped dramatically.

The timing and indication for cerclage affect outcomes. Patients whose cerclage was placed when the cervix had already shortened to 1.5 cm or less had a shorter prolongation of pregnancy compared to those who were treated earlier. This underscores the value of catching cervical shortening early.

Progesterone Versus Cerclage

For singleton pregnancies with a prior preterm birth and a mid-trimester short cervix, the evidence suggests vaginal progesterone and cerclage are similarly effective. An updated indirect comparison meta-analysis found no statistically significant differences between the two approaches in preventing preterm birth or improving perinatal outcomes. A head-to-head randomized trial comparing cerclage, pessary, and vaginal progesterone directly also found similar rates of preterm birth before 37 weeks across all three groups.

In practice, the choice often comes down to the woman’s specific clinical picture and preferences. Vaginal progesterone is noninvasive and does not require surgery or anesthesia. Cerclage involves a surgical procedure and carries a small risk of complications like membrane rupture, though these are uncommon. For women without a prior preterm birth who have a short cervix detected on ultrasound, progesterone is typically the first choice. Cerclage tends to be favored when there is a strong obstetric history suggesting cervical insufficiency, or when the cervix continues to shorten despite progesterone.

The Cervical Pessary

A cervical pessary is a silicone ring placed around the cervix to redistribute the mechanical load and help keep it closed. The device is inserted in the office without anesthesia and removed later in pregnancy. The appeal is obvious: it is noninvasive, inexpensive, and easy to place and remove.

The evidence for pessaries is mixed and depends on the population. In singleton pregnancies with cervical insufficiency, one study found significantly more preterm births in the pessary group compared to the cerclage group (about 46 percent versus 21 percent), suggesting cerclage may be the better option. In the head-to-head randomized trial mentioned above, however, pessary performed similarly to cerclage and progesterone for preterm birth before 37 weeks, though the study may not have been large enough to detect smaller differences between treatments.

Some practitioners now explore combining a pessary with vaginal progesterone. A retrospective study found that the combination led to fewer NICU admissions (about 35 percent versus 54 percent) and less need for neonatal resuscitation compared to progesterone alone. This is preliminary, but combination strategies are an area of active investigation.

What About Twin Pregnancies

Twin pregnancies present a different challenge. The uterus stretches more, the cervix bears more weight, and preterm birth rates are much higher overall. Unfortunately, the treatments that work well for singletons do not always translate.

The pessary has not fared well in twins. A large randomized trial found that the Arabin pessary did not reduce preterm birth or adverse neonatal outcomes in women carrying twins with a short cervix. A smaller historical cohort study comparing pessary plus progesterone to untreated twins also showed no significant benefit.

Cerclage in twins, long considered controversial, has more encouraging recent data. A 2024 meta-analysis found that cerclage in twin pregnancies with a short cervix significantly reduced preterm birth at every threshold studied, from before 37 weeks down to before 28 weeks. Perinatal mortality was also significantly lower with cerclage. A randomized trial comparing cerclage to pessary in twins with a short cervix found that while overall preterm birth rates before 34 weeks were similar between groups, cerclage dramatically reduced very early preterm birth before 28 weeks (one percent versus nearly nine percent) and perinatal death. This is reshaping how specialists think about cerclage for twins, though practice has not fully caught up to the new evidence.

Why Bed Rest Does Not Help

For decades, women diagnosed with a short cervix were told to limit their activity or go on bed rest. This advice sounds intuitive, since reducing physical strain on the cervix seems logical. But the evidence does not support it. A study of asymptomatic women with a short cervix found that activity restriction did not reduce the rate of preterm birth. A prospective pilot study using objective physical activity monitors in women with sonographic short cervical length reached the same conclusion.

Bed rest also carries real downsides: muscle loss, blood clot risk, mood deterioration, and lost income. If your provider recommends activity restriction after finding a short cervix, it is worth asking what evidence supports that recommendation and whether progesterone or another proven treatment might be a better fit.

What Happens When a Cerclage Comes Out

If you have a cerclage in place, it is typically removed electively around 36 to 37 weeks. A common worry is that labor will start immediately once the stitch comes out. In most cases, it does not. One study found that the median interval between elective cerclage removal and the onset of spontaneous labor was 14 days, and only about 18 percent of women went into labor within 72 hours. The average gestational age at delivery after removal was a reassuring 39 weeks. Women whose cerclage was placed for ultrasound-indicated reasons were somewhat more likely to deliver quickly after removal compared to those with a history-indicated cerclage. Complications from the removal procedure itself are rare; one review of outcomes at a single center reported no cases of membrane rupture, hemorrhage, or cervical laceration during removal.

Women With Uterine Anomalies

Women born with structural differences in the uterus, such as a septate, bicornuate, or unicornuate uterus, face elevated preterm birth risks in general. A short cervix in these women may signal more trouble than the same measurement in someone with typical anatomy. One study of women with congenital uterine anomalies found that a short cervix at 24 weeks was moderately predictive of spontaneous preterm birth before 34 weeks, though earlier measurements at 16 or 20 weeks were not as useful. A meta-analysis found that preterm birth occurred in over half of women with uterine anomalies who had a short cervix, compared to about 13 percent of those with a normal cervical length. The risk was eightfold higher overall, and the association was strongest for bicornuate uterus.

For these women, some specialists recommend more frequent cervical length monitoring starting earlier in the second trimester. The treatment options remain the same, progesterone and cerclage, though large randomized trials specific to this subgroup are still lacking.

The Emotional Toll

A diagnosis of cervical insufficiency or short cervix can take a serious psychological toll. The anxiety of knowing your pregnancy is at higher risk of ending early, combined with frequent monitoring visits and possible surgical interventions, creates real emotional strain. A study measuring anxiety and depression scores found that pregnant women with cervical insufficiency had significantly higher levels of both anxiety and depression compared to healthy pregnant women across all trimesters. This held true for mild, moderate, and severe levels of distress.

This is an underappreciated aspect of the condition. If you are navigating a short cervix diagnosis, reaching out for mental health support, whether through a therapist experienced with high-risk pregnancy, a peer support group, or simply a candid conversation with your care team, is a legitimate part of managing your health during this time.

Cervical Elastography and the Future of Prediction

Standard ultrasound measures how long the cervix is, but length alone does not capture the full picture. A cervix can measure 30 mm but already be significantly softer than it should be, while another at 22 mm might still be firm and holding well. Cervical elastography is an emerging ultrasound technique that measures how stiff or soft the cervical tissue is, potentially catching problems that length measurement alone would miss.

A systematic review of 13 studies covering over 4,000 women found that cervical elastography had a pooled sensitivity of about 77 percent and a specificity of about 73 percent for predicting spontaneous preterm birth, with an overall diagnostic accuracy considered moderate to good. Two different types of elastography are being studied. Shear wave elastography tended to perform better in later gestation, while strain elastography showed relatively better results in early to mid-trimester assessments. The technology is not yet part of routine clinical practice, but it represents a promising step toward more personalized risk assessment, especially for women whose cervical length falls in an ambiguous range.

Related Content

More in Pregnancy